As part of its education program titled, Returning to Practice in the Post-COVID-19 Era: Resources for Treating CLL, the Association of Cancer Care Centers (ACCC) is seeking an oncologist to participate in a 30-minute key informant interview to share their experience with managing patients with CLL in the COVID-19/post-COVID-19 era. ACCC will highlight findings from the interviews in a whitepaper on treating CLL in the pandemic era. The interviewee will receive a $100 honorarium.
If interested, please contact Program Manager, Limaya Atembina at latembina@accc-cancer.org. You may also fill out the Volunteer Registry Form by clicking "Apply Now" below and indicating "CLL Interview" when asked if a specific opportunity interests you.
Apply now

Small Cell SMASHERS was founded in 2023 as a patient-centered advocacy and education community designed to challenge long-standing narratives about small cell lung cancer and restore a sense of voice, connection, and hope for patients and their loved ones.

ACCCBuzz spoke with Fox Chase Cancer Center to learn more about its partnership with Omniscope, a leader in advanced molecular profiling technology, in hopes of developing an assay that accurately predicts which patients will respond well to immunotherapy based on the presence of certain T-cell clones.

On Friday, April 17, ACCC welcomed oncology leaders from around the country to Washington, DC for the inaugural ACCC Leadership Summit, a forum designed for executive-level decision-makers to engage in strategic dialogue, peer-to-peer exchange, and actionable insights at the highest level of oncology leadership.

During the HOPA 2026 annual conference, ACCC brought together a small group of oncology pharmacists for a practical, candid conversation about challenges with the implementation of bispecific antibodies that was deeply grounded in real-world experience and what it takes to operationalize care.
